RADNOSTIX, INC. Current Assets
The Current Assets of RADNOSTIX, INC. (INIS) as of Jul 30, 2026 is 1.51 M USD. In the previous year, Current Assets was 3.04 M USD — a change of -50.27% (lower).
Get this data via API
Financial Data API
Current Assets
1.51 MUSD
YoY
-50.27%
Last updated:
Current Assets of RADNOSTIX, INC. is 2026 1.51 M USD. Current Assets of RADNOSTIX, INC. was 2025 3.04 M USD. It decreases by -50.27% lower compared to the previous year.
Access this data via the Eulerpool API
RADNOSTIX, INC. Stock analysis
What does RADNOSTIX, INC. do? International Isotopes Inc. is a company specializing in the production and sale of radioactive isotopes, chemicals, and materials. The company was founded in 1995 and is headquartered in Idaho Falls, Idaho. Its main goal is to meet the demand for high-quality radioactive isotopes for medical and industrial use. Over the years, the company has diversified its business and now offers a wide variety of products and services. It produces and sells a range of radioactive isotopes, chemicals, and materials, including medical and industrial radioisotopes, radiation protection products, and nuclear fuels. Additionally, International Isotopes manufactures and distributes biofuels derived from biomass such as corn and cattle. These biofuels serve as an environmentally friendly alternative to conventional fossil fuels. The company also offers a program for the disposal of radioactive waste, providing services to remove nuclear materials from medical, industrial, and scientific facilities. In terms of medical radioisotopes, International Isotopes produces a wide range of isotopes, including technetium-99, a crucial substance for medical imaging diagnostics. The company also supplies specialized radioactive materials used in cancer diagnostics and radiation therapy. Industrial radioisotopes are another important product line for the company, including materials used in medical radiation therapy, as well as radiation sources used in measurement and control technology. International Isotopes also manufactures various products used in radiation protection, such as protective clothing, shielding materials, and radiation containment vessels. Furthermore, the company is involved in the supply of nuclear fuels for various applications, ranging from military facilities to civilian nuclear power plants. In summary, International Isotopes offers a wide range of products and services, specializing in the important field of radioactive isotopes and providing solutions in the areas of medicine, industry, research, and the environment. RADNOSTIX, INC. is one of the most popular companies on Eulerpool.
Frequently Asked Questions about RADNOSTIX, INC. stock
Current Assets of RADNOSTIX, INC. is 1.51 M USD in 2026.
Access this data via the Eulerpool API
Balance Sheet — RADNOSTIX, INC.
Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets
All Key Metrics — RADNOSTIX, INC.
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth